Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Apieron, a medical device company, has appointed Holly McGarraugh as its new president and CEO, effective immediately. Ms McGarraugh replaces Rich Lotti, who resigned to pursue other business interests.
Subscribe to our email newsletter
Ms McGarraugh has joined Apieron as vice president of marketing in January 2008. Ms McGarraugh was previously vice president of worldwide marketing for in vivo products at Abbott Diabetes Care where she led commercialization efforts, including clinical acceptance and reimbursement, for continuous glucose monitoring, a new product category.
Wende Hutton, board member of Apieron, said: “We chose Holly for the CEO position because of her strong commercialization experience. Holly has made a remarkable contribution to Apieron since she joined the company, and we are confident that she will add considerable value to the company, leading Apieron through commercialization in the asthma therapy marketplace.”